05:56 AM EDT, 03/24/2026 (MT Newswires) -- Eugene Schneider, EVP, Chief Clinical Development Officer, on March 19, 2026, sold 5,812 shares in Ionis Pharmaceuticals ( IONS ) for $412,486. Following the Form 4 filing with the SEC, Schneider has control over a total of 63,890 common shares of the company, with 63,890 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/874015/000087401526000152/xslF345X05/primary_doc.xml